Simos Simeonidis - 09 Jun 2022 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Reporting relationship: Director
Issuer ticker: RGLS
Reported as of: 09 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jun 2022, 16:16:01 UTC
Prior SEC filing: 15 Jun 2021
Source filing: View source filing
Reporting owner signature: Christopher Aker, Attorney in Fact

Key filing fact

Simos Simeonidis filed Form 4 for Regulus Therapeutics Inc. (RGLS) on 10 Jun 2022.

Key facts

This page summarizes Simos Simeonidis's Form 4 filing for Regulus Therapeutics Inc. (RGLS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Jun 2022, 16:16.

Change

Previous filing in this sequence was filed on 15 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RGLS transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +90,000
Change %
Price: $0.000000
Shares after: 90,000
Date: 09 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 90,000
Exercise price: $0.2700
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Pursuant to the Company's Non Employee Director's Compensation policy, the options are automatically granted on the date of the Company's Annual Meeting of Stockholders and will vest ratably over the following twelve months such that the option will be fully vested one year after the date of grant or on the date of the Company's next annual stockholder meeting, whichever occurs first, subject to the Reporting Person's continuous service.